RNA binding protein PUM2 promotes hepatocellular carcinoma proliferation and apoptosis via binding to the 3'UTR of BTG3

Liu,Zhenhua; Lv,Chunye

doi:10.3892/ol.2022.13466

RNA binding protein PUM2 promotes hepatocellular carcinoma proliferation and apoptosis via binding to the 3'UTR of BTG3

Authors:
- Zhenhua Liu
- Chunye Lv
View Affiliations

Affiliations: Department of General Surgery, The First People's Hospital of Lin Ping District, Hangzhou, Zhejiang 311100, P.R. China, Department of General Surgery, The Affiliated Jiangning Hospital with Nanjing Medical University, Nanjing, Jiangsu 211100, P.R. China
Published online on: August 17, 2022 https://doi.org/10.3892/ol.2022.13466
Article Number: 346
Copyright: © Liu et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Pumilio homolog 2 (PUM2) is an RNA‑binding protein that functions as an oncogene in various types of cancer. However, its role in hepatocellular carcinoma (HCC) has remained to be fully elucidated. In the present study, the role of PUM2 was investigated in HCC and its regulation was assessed by examining its binding to the 3'‑untranslated region (UTR) of B‑cell translocation gene 3 (BTG3). The expression levels of PUM2 were determined in datasets from the UALCAN and Cancer Cell Line Encyclopedia databases. Furthermore, Gene Expression Profiling Interactive Analysis was used to analyze overall survival in patients with HCC. Reverse transcription‑quantitative PCR (RT‑qPCR) and western blot analyses were then performed to detect the expression levels of PUM2 and BTG3 in HCC cells. Cell proliferation was assessed using Cell Counting Kit‑8 and colony‑formation assays. The induction of cell apoptosis was evaluated using TUNEL and western blotting assays. StarBase and RNA‑Protein Interaction Prediction were used to determine the possible direct interaction between PUM2 and BTG3. The interaction between PUM2 and BTG3 was then verified by luciferase reporter and RNA‑binding protein immunoprecipitation assays. The results indicated that PUM2 expression was upregulated in HCC tissues and cells and that it was associated with the prognosis of patients with HCC. PUM2 silencing inhibited the proliferation and promoted the apoptosis of Huh‑7 cells. In addition, PUM2 was confirmed to directly bind to the 3'UTR of BTG3. Downregulation of BTG3 reversed the effects of PUM2 silencing on cell proliferation and apoptosis in Huh‑7 cells. Collectively, the results suggested that PUM2 regulated HCC cell proliferation and apoptosis via interacting with BTG3, which may provide a novel therapeutic strategy for the treatment of human HCC.

View Figures

View References

1	Llovet JM, Kelley RK, Villanueva A, Singal AG, Pikarsky E, Roayaie S, Lencioni R, Koike K, Zucman-Rossi J and Finn RS: Hepatocellular carcinoma. Nat Rev Dis Primers. 7:62021. View Article : Google Scholar : PubMed/NCBI
2	Cree IA, Indave Ruiz BI, Zavadil J, McKay J, Olivier M, Kozlakidis Z, Lazar AJ, Hyde C, Holdenrieder S, Hastings R, et al: The international collaboration for cancer classification and research. Int J Cancer. 148:560–571. 2021. View Article : Google Scholar : PubMed/NCBI
3	Kanwal F, Kramer J, Asch SM, Chayanupatkul M, Cao Y and El-Serag HB: Risk of hepatocellular cancer in HCV patients treated with direct-acting antiviral agents. Gastroenterology. 153:996–1005.e1. 2017. View Article : Google Scholar : PubMed/NCBI
4	Estes C, Razavi H, Loomba R, Younossi Z and Sanyal AJ: Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease. Hepatology. 67:123–133. 2018. View Article : Google Scholar : PubMed/NCBI
5	European Association for the Study of the Liver, . Electronic address simpleeasloffice@easloffice.eu. European Association for the Study of the Liver: EASL clinical practice guidelines: Management of hepatocellular carcinoma. J Hepatol. 69:182–236. 2018. View Article : Google Scholar : PubMed/NCBI
6	Llovet JM and Bruix J: Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival. Hepatology. 37:429–442. 2003. View Article : Google Scholar : PubMed/NCBI
7	Abbastabar M, Sarfi M, Golestani A and Khalili E: lncRNA involvement in hepatocellular carcinoma metastasis and prognosis. EXCLI J. 17:900–913. 2018.PubMed/NCBI
8	White EK, Moore-Jarrett T and Ruley HE: PUM2, a novel murine puf protein, and its consensus RNA-binding site. RNA. 7:1855–1866. 2001.PubMed/NCBI
9	Fox M, Urano J and Reijo Pera RA: Identification and characterization of RNA sequences to which human PUMILIO-2 (PUM2) and deleted in Azoospermia-like (DAZL) bind. Genomics. 85:92–105. 2005. View Article : Google Scholar : PubMed/NCBI
10	Cao Y, Liu C, Wang Q, Wang W, Tao E and Wan L: Pum2 mediates Sirt1 mRNA decay and exacerbates hypoxia/reoxygenation-induced cardiomyocyte apoptosis. Exp Cell Res. 393:1120582020. View Article : Google Scholar : PubMed/NCBI
11	Smialek MJ, Kuczynska B, Ilaslan E, Janecki DM, Sajek MP, Kusz-Zamelczyk K and Jaruzelska J: Kinesin KIF18A is a novel PUM-regulated target promoting mitotic progression and survival of a human male germ cell line. J Cell Sci. 133:jcs2409862020. View Article : Google Scholar : PubMed/NCBI
12	Hu R, Zhu X, Chen C, Xu R, Li Y and Xu W: RNA-binding protein PUM2 suppresses osteosarcoma progression via partly and competitively binding to STARD13 3′UTR with miRNAs. Cell Prolif. 51:e125082018. View Article : Google Scholar : PubMed/NCBI
13	Tao W, Ma J, Zheng J, Liu X, Liu Y, Ruan X, Shen S, Shao L, Chen J and Xue Y: Silencing SCAMP1-TV2 inhibited the malignant biological behaviors of breast cancer cells by interaction with PUM2 to facilitate INSM1 mRNA degradation. Front Oncol. 10:6132020. View Article : Google Scholar : PubMed/NCBI
14	Wang Y, Sun W, Yang J, Yang L, Li C, Liu H, Liu X and Jiao B: PUM2 promotes glioblastoma cell proliferation and migration via repressing BTG1 expression. Cell Struct Funct. 44:29–39. 2019. View Article : Google Scholar : PubMed/NCBI
15	Chandrashekar DS, Bashel B, Balasubramanya SAH, Creighton CJ, Ponce-Rodriguez I, Chakravarthi BVSK and Varambally S: UALCAN: A portal for facilitating tumor subgroup gene expression and survival analyses. Neoplasia. 19:649–658. 2017. View Article : Google Scholar : PubMed/NCBI
16	Tang Z, Li C, Kang B, Gao G, Li C and Zhang Z: GEPIA: A web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res. 45:(W1)W98–W102. 2017. View Article : Google Scholar : PubMed/NCBI
17	Li JH, Liu S, Zhou H, Qu LH and Yang JH: starBase v2.0: Decoding miRNA-ceRNA, miRNA-ncRNA and protein-RNA interaction networks from large-scale CLIP-Seq data. Nucleic Acids Res. 42:(Database Issue). D92–D97. 2014. View Article : Google Scholar : PubMed/NCBI
18	Muppirala UK, Honavar VG and Dobbs D: Predicting RNA-protein interactions using only sequence information. BMC Bioinformatics. 12:4892011. View Article : Google Scholar : PubMed/NCBI
19	Bustin SA, Benes V, Garson JA, Hellemans J, Huggett J, Kubista M, Mueller R, Nolan T, Pfaffl MW, Shipley GL, et al: The MIQE guidelines: Minimum information for publication of quantitative real-time PCR experiments. Clin Chem. 55:611–622. 2009. View Article : Google Scholar : PubMed/NCBI
20	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
21	Cao Y, Ren Y, Ma H, Zhou C, Liu J, Shi Q, Feng G, Zheng C and Xiong B: Classification of hepatocellular carcinoma diameter by statistical technology and prognostic evaluation in patients after the combined use of transarterial chemoembolization and radiofrequency ablation. J Cancer Res Ther. 16:356–364. 2020. View Article : Google Scholar : PubMed/NCBI
22	Wang W and Wei C: Advances in the early diagnosis of hepatocellular carcinoma. Genes Dis. 7:308–319. 2020. View Article : Google Scholar : PubMed/NCBI
23	Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
24	Kim DW, Talati C and Kim R: Hepatocellular carcinoma (HCC): Beyond sorafenib-chemotherapy. J Gastrointest Oncol. 8:256–265. 2017. View Article : Google Scholar : PubMed/NCBI
25	Ichikawa T, Sano K and Morisaka H: Diagnosis of pathologically early HCC with EOB-MRI: Experiences and current consensus. Liver Cancer. 3:97–107. 2014. View Article : Google Scholar : PubMed/NCBI
26	Gentile D, Donadon M, Lleo A, Aghemo A, Roncalli M, di Tommaso L and Torzilli G: Surgical treatment of hepatocholangiocarcinoma: A systematic review. Liver Cancer. 9:15–27. 2020. View Article : Google Scholar : PubMed/NCBI
27	Gennarino VA, Singh RK, White JJ, De Maio A, Han K, Kim JY, Jafar-Nejad P, di Ronza A, Kang H, Sayegh LS, et al: Pumilio1 haploinsufficiency leads to SCA1-like neurodegeneration by increasing wild-type Ataxin1 levels. Cell. 160:1087–1098. 2015. View Article : Google Scholar : PubMed/NCBI
28	Chen D, Zheng W, Lin A, Uyhazi K, Zhao H and Lin H: Pumilio 1 suppresses multiple activators of p53 to safeguard spermatogenesis. Curr Biol. 22:420–425. 2012. View Article : Google Scholar : PubMed/NCBI
29	Crittenden SL, Bernstein DS, Bachorik JL, Thompson BE, Gallegos M, Petcherski AG, Moulder G, Barstead R, Wickens M and Kimble J: A conserved RNA-binding protein controls germline stem cells in Caenorhabditis elegans. Nature. 417:660–663. 2002. View Article : Google Scholar : PubMed/NCBI
30	Nishanth MJ and Simon B: Functions, mechanisms and regulation of Pumilio/Puf family RNA binding proteins: A comprehensive review. Mol Biol Rep. 47:785–807. 2020. View Article : Google Scholar : PubMed/NCBI
31	Moore FL, Jaruzelska J, Fox MS, Urano J, Firpo MT, Turek PJ, Dorfman DM and Pera RA: Human Pumilio-2 is expressed in embryonic stem cells and germ cells and interacts with DAZ (Deleted in AZoospermia) and DAZ-like proteins. Proc Natl Acad Sci USA. 100:538–543. 2003. View Article : Google Scholar : PubMed/NCBI
32	Shigunov P, Sotelo-Silveira J, Kuligovski C, de Aguiar AM, Rebelatto CK, Moutinho JA, Brofman PS, Krieger MA, Goldenberg S, Munroe D, et al: PUMILIO-2 is involved in the positive regulation of cellular proliferation in human adipose-derived stem cells. Stem Cells Dev. 21:217–227. 2012. View Article : Google Scholar : PubMed/NCBI
33	Lee MH, Wu X and Zhu Y: RNA-binding protein PUM2 regulates mesenchymal stem cell fate via repression of JAK2 and RUNX2 mRNAs. J Cell Physiol. 235:3874–3885. 2020. View Article : Google Scholar : PubMed/NCBI
34	Duan W, Nian L, Qiao J and Liu NN: LncRNA TUG1 aggravates the progression of cervical cancer by binding PUM2. Eur Rev Med Pharmacol Sci. 23:8211–8218. 2019.PubMed/NCBI
35	Matsuda S, Rouault J, Magaud J and Berthet C: In search of a function for the TIS21/PC3/BTG1/TOB family. FEBS Lett. 497:67–72. 2001. View Article : Google Scholar : PubMed/NCBI
36	Yoneda M, Suzuki T, Nakamura T, Ajima R, Yoshida Y, Kakuta S, Katsuko S, Iwakura Y, Shibutani M, Mitsumori K, et al: Deficiency of antiproliferative family protein Ana correlates with development of lung adenocarcinoma. Cancer Sci. 100:225–232. 2009. View Article : Google Scholar : PubMed/NCBI
37	Yamamoto N, Uzawa K, Yakushiji T, Shibahara T, Noma H and Tanzawa H: Analysis of the ANA gene as a candidate for the chromosome 21q oral cancer susceptibility locus. Br J Cancer. 84:754–759. 2001. View Article : Google Scholar : PubMed/NCBI
38	Liu L, Liu S, Duan Q, Chen L, Wu T, Qian H, Yang S, Xin D, He Z and Guo Y: MicroRNA-142-5p promotes cell growth and migration in renal cell carcinoma by targeting BTG3. Am J Transl Res. 9:2394–2402. 2017.PubMed/NCBI
39	Ren XL, Zhu XH, Li XM, Li YL, Wang JM, Wu PX, Lv ZB, Ma WH, Liao WT, Wang W, et al: Down-regulation of BTG3 promotes cell proliferation, migration and invasion and predicts survival in gastric cancer. J Cancer Res Clin Oncol. 141:397–405. 2015. View Article : Google Scholar : PubMed/NCBI
40	Wang L, Mo H, Jiang Y, Wang Y, Sun L, Yao B, Chen T, Liu R, Li Q, Liu Q and Yin G: MicroRNA-519c-3p promotes tumor growth and metastasis of hepatocellular carcinoma by targeting BTG3. Biomed Pharmacother. 118:1092672019. View Article : Google Scholar : PubMed/NCBI